Product Name: N-[2-[2-hydroxy-4-(methanesulfonamido)-5-phenoxyphenyl]-2-oxoethyl]formamide CAS NO:149457-03-4
Chemical & Physical Properties:
Appearance: White to off-White Powder
Boiling point:622.4℃ at 760 mmHg
Index of Refraction:1.628
Water Solubility: Very slightly soluble (0.11 g/L) (25 ºC)
Iguratimod is a new type of drug for the treatment of rheumatoid arthritis (RA) and osteoarthritis (OA) developed by Japan's Toyama company. Japan applied for marketing in 2003.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.